Patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) are the same as these patients have a greater risk for COVID-19 because of a significant decrease in ACE2 expression [63]. This evidence concerns the gene ACE2 and myalgic encephalomeyelitis/chronic fatigue syndrome.